Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.

Our mission is to discover and develop first-in-class therapeutics and differentiated best-in-class drugs with better efficacy and safety profile. We utilize our deep expertise in medicinal chemistry, structure-based rational drug design combined with high through-put synthesis, translational research and patient-driven precision medicine to develop our targeted therapies. We plan to aggressively resource chemistry for lead optimization and preclinical development to rapidly identify compounds with “best-in-class” target profiles.